Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS In a double-blind...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2011
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26913
Acceso en línea:
https://doi.org/10.1056/NEJMoa1009638
https://repository.urosario.edu.co/handle/10336/26913
Palabra clave:
Randomization
Hypertension
Diabetes
Rights
License
Abierto (Texto Completo)